Follow
Andry Nur Hidayat
Andry Nur Hidayat
PhD Student, Biotechnology Institue - Ankara University
Verified email at ankara.edu.tr - Homepage
Title
Cited by
Cited by
Year
Pharmacophore-based virtual screening for identifying β5 subunit inhibitor of 20S proteasome
M Arba, A Nur-Hidayat, SI Surantaadmaja, DH Tjahjono
Computational Biology and Chemistry 77, 64-71, 2018
152018
Virtual screening of the Indonesian medicinal plant and zinc databases for potential inhibitors of the RNA-dependent RNA polymerase (RdRp) of 2019 novel coronavirus
M Arba, A Nur-Hidayat, I Usman, A Yanuar, ST Wahyudi, G Fleischer, ...
Indonesian Journal of Chemistry 20 (6), 2020
112020
Insight into human protease activated receptor-1 as anticancer target by molecular modelling
AN Hidayat, E Aki-Yalcin, M Beksac, E Tian, SZ Usmani, T Ertan-Bolelli, ...
SAR and QSAR in Environmental Research 26 (10), 795-807, 2015
102015
Determination of the apoptotic effect and molecular docking of benzamide derivative XT5 in K562 cells
T Ozkan, Y Hekmatshoar, T Ertan-Bolelli, AN Hidayat, M Beksac, ...
Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018
72018
Possible mechanism of action of neurokinin-1 receptors (NK1R) antagonists
Ö Öztürk, E Aki-Yalcin, T Ertan-Bolelli, K Bolelli, A Nur-Hidayat, ...
Journal of Pharmacy and Pharmacology 5, 787-797, 2017
62017
Molecular modeling on porphyrin derivatives as β5 subunit inhibitor of 20S proteasome
M Arba, A Nur-Hidayat, M Yusuf, R Hertadi, ST Wahyudi, ...
Computational Biology and Chemistry 74, 230-238, 2018
42018
Expression and in vitro binding of protease activated receptor1 (PAR1) with novel anti-PAR1 molecules: data on fresh myeloma marrow plasma cells and human myeloma cell lines
M Beksac, P Ataca, B Atesagaoglu, K Dalva, AN Hidayat, I Yalcin, EY Aki, ...
Blood 126 (23), 4440, 2015
12015
Frequency Of Protease Activated Receptor1 (PAR1) Expression And The In Vitro Effects Of XT5 And XT2B, Two Novel PAR1 Binding Molecules, On Primary And Bortezomib Refractory …
M Beksac, P Ataca, B Kirazli, K Dalva, AN Hidayat, S Yalcin, E Aki-Yalcin, ...
Clinical Lymphoma, Myeloma and Leukemia 15, e235, 2015
12015
Proteaz ile aktive edilen reseptör 1 (PAR1) üzerinden etkili antikanser bileşiklerin moleküler modelleme yöntemleri ile tasarımları
AN Hidayat
Biyoteknoloji Enstitüsü, 0
An in silico Investigation of the Activation Mechanisms of Clotting Processes by Highly Deacetylated Oligomeric Chitosan
S Elçi, A Hidayat, A OLĞAÇ, E AKI YALÇIN
Investigation of the activation mechanisms of natural clotting processes by highly deacetylated chitosan
S Elçi, K BOLELLİ, A Hidayat, A OLĞAÇ, U Javornik, F BELEN APAK, ...
The system can't perform the operation now. Try again later.
Articles 1–11